Loading data...
TxPPIE Inc.
CEO
Haruka Ichinose
N/A
Recent News & PR
Summary
Message to Participants
Detailed Information
Patients with adverse drug reactions and intractable or rare diseases are dispersed across the country, and traditional methods of accumulating medical information that rely on specific medical institutions cannot quickly obtain sufficient samples, making research progress extremely difficult. Therefore, we collaborate with patient groups to build and operate a platform that collects medical records and samples from patients nationwide. We provide integrated data of accumulated and analyzed clinical information and genomic information to research institutions and pharmaceutical companies to accelerate drug discovery and establish a system to return results to patients.
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
Healthcare / Biotech, AI / データ活用
本社所在地
Tokyo, Japan
設立日
2025年10月23日
資本金
N/A
Employee Count
2人
Industry Outlook & Trends for TxPPIE Inc.
In the AI and data analytics market where TxPPIE Inc. is active, the industry is shifting from proof-of-concept to real business integration. Demand is surging for systems that securely connect proprietary corporate data with AI to automate advanced analysis. In addition to text generation, multimodal AI and autonomous AI agents are accelerating. The key source of competitiveness now lies in maximizing data value, driving growth for innovative leaders like TxPPIE Inc..
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.